Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPRAD Pharma, commonly known as Laboratoires IPRAD, is a prominent French pharmaceutical company specializing in women's health and family well-being. Founded in 1989, the company has built a strong reputation in the pharmacy channel with market-leading brands such as Saforelle for intimate hygiene and Gestarelle for maternity nutrition. Their product portfolio is diverse, encompassing medicines, medical devices, and food supplements designed to address daily health needs. In 2020, IPRAD was acquired by Biocodex, a global pharmaceutical group, to create a leader in the women's health and microbiota sectors. Today, the company continues to innovate in gynecology, nutrition, and general family health as a key subsidiary of the Biocodex group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPRAD Pharma.